Desmopressin Acetate (Desmopressin Acetate)

Select Strength and Packaging*

Ask for Quote

Trade Name: Desmopressin Acetate

Following information is meant for : Wholesalers, Suppliers, Exporters, Doctors, CROs, Comparator Supplies, Hospitals, MOH Tender Supplies, Generic, Brand, Cooperate Sourcing, India, Institutional Buyers.

Manufacturer: Amring Pharmaceuticals Inc.

Presentation: TABLET, HUMAN PRESCRIPTION DRUG

Strength: 0.1 mg/1

Storage and handling

DESMOPRESSIN ACETATE Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [CS]

Disclaimer:

These products are NOT FOR SALE in US territories. We offer them for Exports outside of US Territories to Trade Professionals or patients with a valid prescription.
Trademark shown are property of their respective owners and GNH India does not lay any claim on them.

No data

Desmopressin Acetate Tablets
Mol. Wt. 1183.34 Empirical Formula: CHNOSu2022CHOu20223HO
1-(3-mercaptopropionic acid)-8-D-arginine vasopressin monoacetate (salt) trihydrate.
Desmopressin Acetate Tablets

Desmopressin Acetate Tablets

No data

Desmopressin Acetate Tabletsn- Desmopressin Acetate Tablets
Desmopressin acetate is contraindicated in patients with moderate to severe renal impairment (defined as a creatinine clearance below 50 mL/min).
Desmopressin acetate is contraindicated in patients with hyponatremia or a history of hyponatremia.

1. Very rare cases of hyponatremia have been reported from world-wide postmarketing experience in patients treated with desmopressin acetate. Desmopressin acetate is a potent antidiuretic which, when administered, may lead to water intoxication and/or hyponatremia. Unless properly diagnosed and treated hyponatremia can be fatal. Therefore, fluid restriction is recommended and should be discussed with the patient and/or guardian. Careful medical supervision is required.
2. When Desmopressin Acetate Tablets are administered, in particular in pediatric and geriatric patients, fluid intake should be adjusted downward to decrease the potential occurrence of water intoxication and hyponatremia. (See , n and n .) All patients receiving desmopressin acetate therapy should be observed for the following signs of symptoms associated with hyponatremia: headache, nausea/vomiting, decreased serum sodium, weight gain, restlessness, fatigue, lethargy, disorientation, depressed reflexes, loss of appetite, irritability, muscle weakness, muscle spasms or cramps and abnormal mental status such as hallucinations, decreased consciousness and confusion. Severe symptoms may include one or a combination of the following: seizure, coma and/or respiratory arrest. Particular attention should be paid to the possibility of the rare occurrence of an extreme decrease in plasma osmolality that may result in seizures which could lead to coma.
3. Desmopressin acetate should be used with caution in patients with habitual or psychogenic polydipsia who may be more likely to drink excessive amounts of water, putting them at greater risk of hyponatremia.

No data

Infrequently, large doses of the intranasal formulations of desmopressin acetate and Desmopressin Acetate Injection have produced transient headache, nausea, flushing and mild abdominal cramps. These symptoms have disappeared with reduction in dosage.

Signs of overdose may include confusion, drowsiness, continuing headache, problems with passing urine and rapid weight gain due to fluid retention. (See .) In case of overdose, the dose should be reduced, frequency of administration decreased, or the drug withdrawn according to the severity of the condition. There is no known specific antidote for desmopressin acetate. The patient should be observed and treated with appropriate symptomatic therapy.
An oral LD has not been established. Oral doses up to 0.2 mg/kg/day have been administered to dogs and rats for 6 months without any significant drug-related toxicities reported. An intravenous dose of 2 mg/kg in mice demonstrated no effect.

No data

Store at Controlled Room Temperature 20 to 25u00b0C (68 to 77u00b0F) [see USP]. Avoid exposure to excessive heat or light.
This product should be dispensed in a container with a child-resistant cap.
Keep out of the reach of children.

Manufactured for:Amring Pharmaceuticals Inc.Berwyn, PA 19312www.amringusa.comn n
The Amring Logo and the u201cAu201d Logo are trademarks of Amring Pharmaceuticals, Inc.
Origin Sweden
Rev. 08/2020

NDCn- 101n- Rx Only
Desmopressin AcetateTablets
0.1 mg
100 Tablets

NDCn- 201n- Rx Only
Desmopressin AcetateTablets
0.2 mg
100 Tablets

Select Strength and Packaging*

Ask for Quote

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of Desmopressin Acetate (Desmopressin Acetate) which is also known as Desmopressin Acetate and Manufactured by Amring Pharmaceuticals Inc.. It is available in strength of 0.1 mg/1.

Desmopressin Acetate (Desmopressin Acetate) is supplied for Tenders, Emergency imports, Un - licensed, Specials, Orphan drug, Name patient line, RLD supplies, Reference listed drugs, Comparator Drug, Bio-Similar, Innovator samples, For Clinical trials. Click to know price.